NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
15 hedge funds and large institutions have $1.12M invested in InVivo Therapeutics Holdings Corp in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$189K | |
| 2 | +$170K | |
| 3 | +$39K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$23K |
| 5 |
JPMorgan Chase & Co
New York
|
+$4K |
Top Sellers
| 1 | -$78K | |
| 2 | -$23K | |
| 3 | -$18K | |
| 4 |
ICM
IMS Capital Management
Portland,
Oregon
|
-$2.69K |
| 5 |
Morgan Stanley
New York
|
-$1.14K |